| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 37.857 | 116.608 | 174.166 | 121.838 | 0 | 123.370 | 225.460 | 288.764 | 284.931 |
| Total Income - EUR | - | 37.857 | 116.608 | 174.166 | 121.838 | 0 | 123.370 | 225.460 | 288.764 | 284.931 |
| Total Expenses - EUR | - | 202 | 932 | 522 | 588 | 899 | 589 | 1.231 | 8.672 | 9.901 |
| Gross Profit/Loss - EUR | - | 37.656 | 115.676 | 173.644 | 121.250 | -899 | 122.781 | 224.229 | 280.092 | 275.029 |
| Net Profit/Loss - EUR | - | 36.520 | 112.163 | 168.419 | 117.595 | -899 | 119.154 | 218.730 | 277.262 | 266.652 |
| Employees | - | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Chirurgie Oculoplastica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 194 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Current Assets | - | 37.921 | 149.994 | 170.699 | 119.195 | 93 | 120.390 | 220.789 | 280.090 | 437.939 |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | 19.662 | 2 | 3.977 | 0 | 0 | 0 | 219.998 | 0 | 166.500 |
| Cash | - | 18.259 | 149.991 | 166.722 | 119.195 | 93 | 120.390 | 791 | 280.090 | 271.439 |
| Shareholders Funds | - | 36.565 | 148.940 | 169.450 | 118.606 | 93 | 119.245 | 219.703 | 278.233 | 267.617 |
| Social Capital | - | 45 | 876 | 860 | 843 | 827 | 809 | 811 | 809 | 804 |
| Debts | - | 1.550 | 1.053 | 1.249 | 588 | 0 | 1.145 | 1.086 | 1.857 | 170.322 |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Chirurgie Oculoplastica Srl